Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

credit_-_daniel_leal-olivas-afp

Use of Genzyme’s MS drug Lemtrada restricted under ongoing EMA safety review

April 16, 2019 Manufacturing and Production, Sales and Marketing EMA, Genzyme, Lemtrada, multiple sclerosis, pharma

The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety issues …
News
genentech_web

Genentech employee awarded $250,000 over racial discrimination case

April 16, 2019 Manufacturing and Production Genentech, discrimination, pharma, racial discrimination, racism

A US jury has awarded a former Genentech employee nearly $250,000 after the black worker was fired from the firm …
News
andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 16, 2019 Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
News
janssen_latest_logo_on_sign

Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease

April 16, 2019 Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma

Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
News

Half of patients have sub-optimal response to statins, research shows

April 16, 2019 Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins

Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
News
about2medical

Medical cannabis: A green light for patients in need?

April 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Feature

Bayer VP elected to two of the firm’s executive committees

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Appointment
manabe

Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Appointment
darren_cline

GW Pharma announce Darren Cline as company’s new Chief Commercial Officer

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
News
hannah_pender

Living with a rare chromosome disorder

April 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …
Feature
1468995876_rb-centre-for-scientific-excellence

Reckitt Benckiser to unveil £105 R&D site in Hull by end of June

April 11, 2019 Manufacturing and Production Hull, R&D, Reckitt Benckiser, UK, pharma

Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …
News
shutterstock_57369385

Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues

April 9, 2019 Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma

The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …
News
credit_rich_s

United Therapeutics terminates oral pulmonary arterial hypertension drug following Phase 3 failure

April 9, 2019 Manufacturing and Production, Research and Development Tyvaso, United Therapeutics, pharma, pulmonary arterial hypertension

United Therapeutics has revealed in a short announcement that, because its pulmonary arterial hypertension (PAH) therapy failed to meet its …
News
shutterstock_349943306

FDA refuses to review Zogenix’s Fintepla in Dravet syndrome, shares tumble 30%

April 9, 2019 Manufacturing and Production, Sales and Marketing Dravet Syndrome, FDA, Fintepla, Zogenix

California-based biopharma firm Zogenix has been left frustrated after it received a correspondence from the FDA noting its refusal to …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026